Global In - Vitro ADME Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030
In-vitro ADME (Absorption, Distribution, Metabolism, and Excretion) services are a set of techniques used in drug development to assess the pharmacokinetic properties of a compound before it is tested in animals or humans. These services involve the use of in-vitro assays to measure how a compound is absorbed, distributed, metabolized, and eliminated by the body. In-vitro ADME services can provide critical information about a compound's potential efficacy and safety profile, and can help identify potential issues early in the drug development process.
According to our (Global Info Research) latest study, the global In - Vitro ADME Services market size was valued at US$ 980 million in 2023 and is forecast to a readjusted size of USD 1715 million by 2030 with a CAGR of 8.2% during review period.
The core manufacturers of global in-vitro ADME services include Charles River, Labcorp, Envigo, Curia, Evotec and Bioduro-Sundia. The top five manufacturers account for approximately 39% of the global share. Charles River is the world's largest in-vitro ADME services provider, with a market share of approximately 16%.
The United States is the world's largest in-vitro ADME services market, accounting for nearly 48% of the market share. The second and third places are Europe and Asia-Pacific, accounting for 29% and 20% respectively.
In terms of product types, small molecule occupies a dominant position, accounting for 75% of the market share. At the same time, in terms of end users, biopharmaceutical companies are the largest end users, accounting for 84%.
This report is a detailed and comprehensive analysis for global In - Vitro ADME Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global In - Vitro ADME Services market size and forecasts, in consumption value ($ Million), 2019-2030
Global In - Vitro ADME Services market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global In - Vitro ADME Services market size and forecasts, by Type and by End User, in consumption value ($ Million), 2019-2030
Global In - Vitro ADME Services market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for In - Vitro ADME Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global In - Vitro ADME Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, Labcorp, Envigo, Curia, Evotec, Bioduro-Sundia, Lonza, WuXi AppTec, IQVIA, Tecan Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
In - Vitro ADME Services market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
In - Vitro ADME Services market is split by Type and by End User. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Small Molecules
Biologics
Market segment by End User
Biopharmaceutical Companies
Government and Academic Institutes
Others
Market segment by players, this report covers
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe In - Vitro ADME Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of In - Vitro ADME Services, with revenue, gross margin, and global market share of In - Vitro ADME Services from 2019 to 2024.
Chapter 3, the In - Vitro ADME Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by End User, with consumption value and growth rate by Type, by End User, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and In - Vitro ADME Services market forecast, by regions, by Type and by End User, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of In - Vitro ADME Services.
Chapter 13, to describe In - Vitro ADME Services research findings and conclusion.